Klaus Dörte, Härtel Heiko, Fitzpatrick Lynda M, Froehlich John E, Hubert Jamie, Benning Christoph, Dörmann Peter
Max-Planck-Institut für Molekulare Pflanzenphysiologie, 14476 Golm, Germany.
Plant Physiol. 2002 Mar;128(3):885-95. doi: 10.1104/pp.010780.
Galactolipid biosynthesis in plants is highly complex. It involves multiple pathways giving rise to different molecular species. To assess the contribution of different routes of galactolipid synthesis and the role of molecular species for growth and photosynthesis, we initiated a genetic approach of analyzing double mutants of the digalactosyldiacylglycerol (DGDG) synthase mutant dgd1 with the acyltransferase mutant, act1, and the two desaturase mutants, fad2 and fad3. The double mutants showed different degrees of growth retardation: act1,dgd1 was most severely affected and growth of fad2,dgd1 was slightly reduced, whereas fad3,dgd1 plants were very similar to dgd1. In act1,dgd1, lipid and chlorophyll content were reduced and photosynthetic capacity was affected. Molecular analysis of galactolipid content, fatty acid composition, and positional distribution suggested that the growth deficiency is not caused by changes in galactolipid composition per se. Chloroplasts of dgd1 were capable of synthesizing monogalactosyldiacylglycerol, DGDG, and tri- and tetragalactosyldiacylglycerol. Therefore, the reduced growth of act1,dgd1 and fad2,dgd1 cannot be explained by the absence of DGDG synthase activity from chloroplasts. Molecular analysis of DGDG accumulating in the mutants during phosphate deprivation suggested that similarly to the residual DGDG of dgd1, this additional lipid is synthesized in association with chloroplast membranes through a pathway independent of the mutations, act1, dgd1, fad2, and fad3. Our data imply that the severe growth defect of act1,dgd1 is caused by a reduced metabolic flux of chloroplast lipid synthesis through the eukaryotic and prokaryotic pathway as well as by the reduction of photosynthetic capacity caused by the destabilization of photosynthetic complexes.
植物中的半乳糖脂生物合成非常复杂。它涉及多个途径,产生不同的分子种类。为了评估半乳糖脂合成不同途径的贡献以及分子种类对生长和光合作用的作用,我们启动了一项遗传学方法,分析二半乳糖基二酰基甘油(DGDG)合酶突变体dgd1与酰基转移酶突变体act1以及两个去饱和酶突变体fad2和fad3的双突变体。双突变体表现出不同程度的生长迟缓:act1,dgd1受影响最严重,fad2,dgd1的生长略有降低,而fad3,dgd1植株与dgd1非常相似。在act1,dgd1中,脂质和叶绿素含量降低,光合能力受到影响。对半乳糖脂含量、脂肪酸组成和位置分布的分子分析表明,生长缺陷并非由半乳糖脂组成本身的变化引起。dgd1的叶绿体能够合成单半乳糖基二酰基甘油、DGDG以及三半乳糖基二酰基甘油和四半乳糖基二酰基甘油。因此,act1,dgd1和fad2,dgd1生长减缓不能用叶绿体中缺乏DGDG合酶活性来解释。对磷缺乏期间突变体中积累的DGDG的分子分析表明,与dgd1的残留DGDG类似,这种额外的脂质是通过一条独立于act1、dgd1、fad2和fad3突变的途径与叶绿体膜结合合成的。我们的数据表明,act1,dgd1严重的生长缺陷是由叶绿体脂质合成通过真核和原核途径的代谢通量降低以及光合复合体不稳定导致的光合能力降低引起的。